Published in J Pediatr on April 01, 1963
AN OUTBREAK OF ASEPTIC MENINGITIS DUE TO ECHO 25 VIRUS. Can Med Assoc J (1964) 0.98
Impact on routine diagnosis of echovirus infections of intratypic differentiation and antigenic variation in echovirus type 25 studied by using monoclonal antibodies. J Clin Microbiol (1990) 0.94
Infectious Diseases: Annual Review of Significant Publications. Postgrad Med J (1963) 0.75
Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. Ann Intern Med (1961) 12.08
The vacuolating virus, S.V. 40. Proc Soc Exp Biol Med (1960) 7.32
Recovery of new agent from patients with acute respiratory illness. Proc Soc Exp Biol Med (1954) 6.51
The carrier state in viral hepatitis. J Am Med Assoc (1954) 3.96
New antigenic variant in Far East influenza epidemic, 1957. Proc Soc Exp Biol Med (1957) 3.82
Some factors associated with the development of coronary heart disease: six years' follow-up experience in the Framingham study. Am J Public Health Nations Health (1959) 3.48
Development of tumors in hamsters inoculated in the neonatal period with vacuolating virus, SV-40. Proc Soc Exp Biol Med (1962) 3.32
TESTS IN HAMSTERS FOR ONCOGENIC QUALITY OF ORDINARY VIRUSES INCLUDING ADENOVIRUS TYPE 7. Proc Soc Exp Biol Med (1964) 3.15
A skin test for infectious hepatitis. Proc Soc Exp Biol Med (1950) 3.13
Characterization and classification of ECHO 28-rhinovirus-coryzavirus agents. Proc Soc Exp Biol Med (1962) 3.06
Antigenic pattern of strains of influenza A and B. Proc Soc Exp Biol Med (1950) 2.70
Studies of acute respiratory illnesses caused by respiratory syncytial virus. 2. Epidemiology and assessment of importance. N Engl J Med (1961) 2.66
Clinical trials in infants of orally administered attenuated poliomyelitis viruses. Pediatrics (1959) 2.58
Purification and characterization of chick embryo interferon. Proc Soc Exp Biol Med (1963) 2.57
Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. IV. Final report of results based on clinical diagnoses. J Am Med Assoc (1953) 2.56
The indirect complement fixation hemagglutination and conglutinating complement absorption tests for viruses of the psittacosis-lymphogranuloma venereum group. J Immunol (1951) 2.39
Human plasmapheresis and its effect on antibodies. J Immunol (1957) 2.35
Infectious hepatitis; length of protection by immune serum globulin (gamma globulin) during epidemics. J Am Med Assoc (1951) 2.29
Immunization of infants with living attenuated poliomyelitis virus; laboratory investigations of alimentary infection and antibody response in infants under six months of age with congenitally acquired antibodies. J Am Med Assoc (1956) 2.24
Pyridoxine dependency: report of a case of intractable convulsions in an infant controlled by pyridoxine. Pediatrics (1954) 2.17
Studies of acute respiratory illnesses caused by respiratory syncytial virus. 3. Clinical and laboratory findings. N Engl J Med (1961) 2.11
Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 3. Preliminary report of results based on clinical diagnosis. J Am Med Assoc (1952) 2.11
Distribution and significance of Asian and other influenza antibodies in the human population. N Engl J Med (1958) 1.97
Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. 2. Conduct and early follow-up of 1952 Texas and Iowa-Nebraska studies. J Am Med Assoc (1952) 1.93
Acute respiratory illnesses among children and adults. Field study of contemporary importance of several viruses and appraisal of the literature. JAMA (1962) 1.92
Evaluation of Red Cross gamma globulin as a prophylactic agent for poliomyelitis. I. Plan of controlled field tests and results of 1951 pilot study in Utah. J Am Med Assoc (1952) 1.90
System for measuring and designating antigenic components of influenza viruses with analyses of recently isolated strains. Proc Soc Exp Biol Med (1951) 1.88
EFFECTIVE TREATMENT OF EXPERIMENTAL HERPES SIMPLEX KERATITIS WITH NEW DERIVATIVE, 5-METHYLAMINO-2'-DEOXYURIDINE (MADU). Proc Soc Exp Biol Med (1965) 1.84
Adenoviruses: group name proposed for new respiratory-tract viruses. Science (1956) 1.82
Influence of non-specific inhibitor on the diagnostic hemagglutination-inhibition test for influenza. J Immunol (1953) 1.81
Endemic infectious hepatitis in an infants' orphanage. I. Epidemiologic studies in student nurses. AMA Arch Intern Med (1952) 1.76
Contributions to characterization and classification of animal viruses. Proc Soc Exp Biol Med (1963) 1.73
Epidemiology of viral hepatitis A. Am J Public Health Nations Health (1953) 1.72
Laboratory studies on the 1950 outbreak of influenza. Public Health Rep (1950) 1.67
Recovery of new viruses (coryzavirus) from cases of common cold in human adults. Proc Soc Exp Biol Med (1961) 1.67
Use of living attenuated measles-virus vaccine in early infancy. N Engl J Med (1960) 1.62
Infections due to group B beta-hemolytic streptococci. Report of three cases and review of the literature. N Engl J Med (1962) 1.60
Living attenuated measles-virus vaccine in early infancy. Studies of the role of passive antibody in immunization. N Engl J Med (1961) 1.60
Biophysical characterization of the RI (RI-67) viruses. Proc Soc Exp Biol Med (1955) 1.56
Epidemiology of infectious hepatitis and problems of prevention and control. J Am Med Assoc (1952) 1.54
Epidemiology of RI(RI-67) group respiratory virus infections in recruit populations. Am J Hyg (1955) 1.47
Antibody response in volunteers to Asian influenza vaccine. J Am Med Assoc (1958) 1.45
Studies on the complement fixing antigens of poliomyelitis. I. Demonstration of type and group specific antigens in native and heated viral preparations. J Immunol (1958) 1.44
Search for virus in human malignancies. I. In vitro studies. Proc Soc Exp Biol Med (1962) 1.44
Studies of acute respiratory illnesses caused by respiratory syncytial virus. 1. Laboratory findings in 109 cases. Proc Soc Exp Biol Med (1961) 1.43
Observations on the concentrating and diluting mechanisms of the diseased kidney. J Clin Invest (1959) 1.43
Prevention of acute respiratory illness in recruits by adenovirus (RI-APC-ARD) vaccine. Proc Soc Exp Biol Med (1956) 1.43
ATTEMPTS TO INTERRUPT VIRUS TUMORIGENESIS BY IMMUNIZATION USING HOMOLOGOUS "BJORKLUND-TYPE" ANTIGEN. Proc Soc Exp Biol Med (1963) 1.41
Studies on the agent of infectious hepatitis; propagation of the agent in tissue culture and in the embryonated hen's egg. J Exp Med (1950) 1.40
Elimination of nonspecific components from viral antigens by fluorocarbon. J Immunol (1958) 1.36
Epidemiologic investigations with respiratory disease virus RI-67. Am J Public Health Nations Health (1955) 1.34
Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. III. Evaluation of an SF-4 (shipping fever) virus vaccine in cattle. J Immunol (1961) 1.33
INTERRUPTION OF SV-40 VIRUS TUMORIGENESIS USING IRRADIATED HOMOLOGOUS TUMOR ANTIGEN. Proc Soc Exp Biol Med (1964) 1.32
Persistent immunity following Enders live, attenuated measles-virus vaccine given with human immune globulin. N Engl J Med (1962) 1.31
NEW METABOLIZABLE IMMUNOLOGIC ADJUVANT FOR HUMAN USE. I. DEVELOPMENT AND ANIMAL IMMUNE RESPONSE. Proc Soc Exp Biol Med (1964) 1.30
Influenza antibodies in the population of the USA; an epidemiological investigation. Bull World Health Organ (1953) 1.30
Studies on the agent of infectious hepatitis; the disease produced in human volunteers by the agent cultivated in tissue culture or embryonated hen's eggs. J Exp Med (1950) 1.29
The persistence in the human circulation of horse and human tetanus antitoxins. J Pediatr (1961) 1.29
Ender's live measles-virus vaccine with human immune globulin. II. Evaluation of efficacy. Am J Dis Child (1962) 1.25
Appraisal of occurrence of adenovirus-caused respiratory illness in military populations. Am J Hyg (1957) 1.24
Viral hepatitis in the newborn; clinical features, epidemiology, and pathology. AMA Am J Dis Child (1951) 1.24
A safe high-speed blendor for processing infectious materials. J Lab Clin Med (1958) 1.21
Laboratory and field investigations of bovine Myxovirus parainfluenza 3 virus and vaccine. I. Properties of the SF-4 (shipping fever) strain of virus. J Immunol (1961) 1.20
Factors influencing tumor induction in hamsters by vacuolating virus, SV. Proc Soc Exp Biol Med (1963) 1.20
Preparation of dried antigen and antiserum for the agglutination-inhibition test for virus influenza. Public Health Rep (1951) 1.20
Clinical and laboratory findings in cases of respiratory illness caused by coryzaviruses. Ann Intern Med (1962) 1.20
EPIDEMIOLOGIC INVESTIGATIONS OF RHINOVIRUS INFECTIONS. Proc Soc Exp Biol Med (1964) 1.19
ADDITIONAL RHINOVIRUS SEROTYPES. Proc Soc Exp Biol Med (1965) 1.19
Endemic infectious hepatitis in an infants' orphanage. II. Epidemiologic studies in infants and small children. AMA Arch Intern Med (1952) 1.18
Epidemiology of adenovirus respiratory infections in military recruit populations. Ann N Y Acad Sci (1957) 1.18
Effect of Westphal lipid A on viral activities in mice and hamsters. Proc Soc Exp Biol Med (1962) 1.15
Studies on the use of aureomycin in hepatic disease. III. A note on aureomycin therapy in hepatic coma. Am J Med Sci (1950) 1.13